Quarterly report pursuant to Section 13 or 15(d)

Derivative Instruments (Tables)

v3.21.2
Derivative Instruments (Tables)
9 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of Derivative Financial Instruments by Balance Sheet Location The following table sets forth the fair value of the Company's commodity contract derivatives and amounts that offset within the Condensed Consolidated Balance Sheets:
    September 30, 2021 December 31, 2020
    Assets Liabilities Assets Liabilities
Gross amounts of derivatives recognized at fair value $ 6,251  $ 10,227  $ 3,458  $ 12,164 
Cash collateral paid (received) 8,568  —  14,139  — 
Total gross amount recognized 14,819  10,227  17,597  12,164 
Gross amounts offset (10,227) (10,227) (12,164) (12,164)
Net amount reported in the condensed consolidated balance sheets $ 4,592  $ —  $ 5,433  $ — 
Summary of Derivative Financial Instruments by Location of Gain (Loss)
The following table sets forth the commodity contract derivatives gains and (losses) included in the Condensed Consolidated Statements of Operations:
    Location of Gain (Loss)
Recognized in income
Three months ended September 30, 2021 Three months ended September 30, 2020 Nine months ended September 30, 2021 Nine months ended September 30, 2020
Commodity derivatives Cost of goods sold – Bio-based diesel $ (11,640) $ 7,486  $ (394) $ 56,253